Professional Documents
Culture Documents
10.1016@s0140-67361630506-2-Studiul Din 32 de Țări
10.1016@s0140-67361630506-2-Studiul Din 32 de Țări
10.1016@s0140-67361630506-2-Studiul Din 32 de Țări
Summary
Background Stroke is a leading cause of death and disability, especially in low-income and middle-income countries. Published Online
We sought to quantify the importance of potentially modifiable risk factors for stroke in different regions of the world, July 15, 2016
http://dx.doi.org/10.1016/
and in key populations and primary pathological subtypes of stroke. S0140-6736(16)30506-2
See Online/Comment
Methods We completed a standardised international case-control study in 32 countries in Asia, America, Europe, http://dx.doi.org/10.1016/
Australia, the Middle East, and Africa. Cases were patients with acute first stroke (within 5 days of symptom onset and S0140-6736(16)30679-1
72 h of hospital admission). Controls were hospital-based or community-based individuals with no history of stroke, *See appendix for a full list of
and were matched with cases, recruited in a 1:1 ratio, for age and sex. All participants completed a clinical assessment study investigators
and were requested to provide blood and urine samples. Odds ratios (OR) and their population attributable risks Population Health Research
Institute, McMaster University
(PARs) were calculated, with 99% confidence intervals.
and Hamilton Health Sciences,
Hamilton, ON, Canada
Findings Between Jan 11, 2007, and Aug 8, 2015, 26 919 participants were recruited from 32 countries (13 447 cases (M J O’Donnell PhD, S L Chin,
[10 388 with ischaemic stroke and 3059 intracerebral haemorrhage] and 13 472 controls). Previous history of S Rangarajan MSc,
P Rao-Melacini MSc,
hypertension or blood pressure of 140/90 mm Hg or higher (OR 2·98, 99% CI 2·72–3·28; PAR 47·9%, 99% CI
X Zhang MSc, S Agapay BSc,
45·1–50·6), regular physical activity (0·60, 0·52–0·70; 35·8%, 27·7–44·7), apolipoprotein (Apo)B/ApoA1 ratio Prof M J McQueen MBChB,
(1·84, 1·65–2·06 for highest vs lowest tertile; 26·8%, 22·2–31·9 for top two tertiles vs lowest tertile), diet (0·60, M Dehghan PhD, G Pare MD,
0·53–0·67 for highest vs lowest tertile of modified Alternative Healthy Eating Index [mAHEI]; 23·2%, 18·2–28·9 for Prof S Yusuf DPhil); Health
Research Board Clinical Research
lowest two tertiles vs highest tertile of mAHEI), waist-to-hip ratio (1·44, 1·27–1·64 for highest vs lowest tertile;
Facility, Department of
18·6%, 13·3–25·3 for top two tertiles vs lowest), psychosocial factors (2·20, 1·78–2·72; 17·4%, 13·1–22·6), current Medicine, NUI Galway, Galway,
smoking (1·67, 1·49–1·87; 12·4%, 10·2–14·9), cardiac causes (3·17, 2·68–3·75; 9·1%, 8·0–10·2), alcohol Ireland (M J O’Donnell,
consumption (2·09, 1·64–2·67 for high or heavy episodic intake vs never or former drinker; 5·8%, 3·4–9·7 for J Ferguson PhD); St John’s
Medical College and Research
current alcohol drinker vs never or former drinker), and diabetes mellitus (1·16, 1·05–1·30; 3·9%, 1·9–7·6) were
Institute, Bangalore, India
associated with all stroke. Collectively, these risk factors accounted for 90·7% of the PAR for all stroke worldwide (Prof D Xavier MD,
(91·5% for ischaemic stroke, 87·1% for intracerebral haemorrhage), and were consistent across regions (ranging Prof P Pais MD); National Center
from 82·7% in Africa to 97·4% in southeast Asia), sex (90·6% in men and in women), and age groups (92·2% in of Cardiovascular Disease,
Beijing, China (Prof L Liu MD);
patients aged ≤55 years, 90·0% in patients aged >55 years). We observed regional variations in the importance of Beijing Hypertension League
individual risk factors, which were related to variations in the magnitude of ORs (rather than direction, which we Institute, Beijing, China
observed for diet) and differences in prevalence of risk factors among regions. Hypertension was more associated (Prof H Zhang MD,
with intracerebral haemorrhage than with ischaemic stroke, whereas current smoking, diabetes, apolipoproteins, Prof X Wang PhD); Instituto de
Investigaciones FOSCAL,
and cardiac causes were more associated with ischaemic stroke (p<0·0001). Escuela de Medicina,
Universidad de Santander,
Interpretation Ten potentially modifiable risk factors are collectively associated with about 90% of the PAR of stroke Bucaramanga, Colombia
in each major region of the world, among ethnic groups, in men and women, and in all ages. However, we found (Prof P Lopez-Jaramillo PhD);
Eduardo Mondlane University,
important regional variations in the relative importance of most individual risk factors for stroke, which could Maputo, Mozambique
contribute to worldwide variations in frequency and case-mix of stroke. Our findings support developing both global (A Damasceno MD); Academic
and region-specific programmes to prevent stroke. Section of Geriatric Medicine,
Glasgow Royal Infirmary,
University of Glasgow, Glasgow,
Funding Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada, Canadian Stroke Network, UK (Prof P Langhorne PhD);
Health Research Board Ireland, Swedish Research Council, Swedish Heart and Lung Foundation, The Health & Sahlgrenska University Hospital
Medical Care Committee of the Regional Executive Board, Region Västra Götaland (Sweden), AstraZeneca, Boehringer and Sahlgrenska Academy,
Ingelheim (Canada), Pfizer (Canada), MSD, Chest, Heart and Stroke Scotland, and The Stroke Association, with University of Gothenburg,
Gothenburg, Sweden
support from The UK Stroke Research Network.
follow-up. We included cases with acute ischaemic stroke we used a combined measure of psychosocial stress used Rush Alzheimer Disease
and intracerebral haemorrhage in this Article. in INTERHEART, which combines measures of stress Research Center, Rush
University Medical Center,
Controls were either community-based or hospital- (home and work), life events, and depression.13 Atrial Chicago, IL, USA
based. Hospital-based controls were patients admitted to fibrillation or flutter was based on previous history, (Prof S Oveisgharan MD);
hospital or those attending an outpatient clinic for review of baseline electrocardiograph results (for cases Department of Medicine,
disorders or procedures not related to stroke or transient and controls), and results of cardiac monitoring (when University of Limpopo,
Pretoria, South Africa
ischaemic attack, or visitors or relatives of other available). Classification of previous myocardial (D Magazi MD); Neurology
inpatients.10 Specific approaches to identifying sources of infarction, prosthetic heart valve, and rheumatic valvular Division, Department of
community-based controls were not prespecified, because heart disease was based on medical history. Medicine, Siriraj Hospital,
standardised approaches might not be feasible in all Non-fasting blood samples (20 mL) were taken from Mahidol University, Bangkok,
Thailand (Y Nilanont MD); and
settings. However, site guidance on preferred and cases and controls within 72 h of recruitment, separated King Saud University, Riyadh,
acceptable sources for hospital-based controls were by centrifugation and aliquoted into six equal volumes, Saudi Arabia (F Al-Hussain MD)
provided at each site (appendix p 3). and frozen at –20°C or –70°C immediately after Correspondence to:
Each control was matched for sex and age (±5 years) processing. Samples were shipped in nitrogen vapour Dr Martin J O’Donnell,
with cases; age-matching was extended (±10 years) for tanks by courier from every site to a blood storage site, Population Health Research
Institute, DBCVS Research
participants older than 90 years. where they were stored at –160°C in liquid nitrogen Institute, McMaster University,
The study was approved by the ethics committees in all vapour (Clinical Research Laboratory and Biobank, 3rd Floor, 237 Barton St East,
participating centres. All participants, or their proxy, Hamilton, ON, Canada) or at –70°C in the National Hamilton, ON, L8L 2X2, Canada
provided written informed consent before taking part in Coordinating Offices in India, Turkey, and China. All odonnm@mcmaster.ca
the study. data were transferred to the Population Health Research See Online for appendix
Institute, McMaster University and Hamilton Health
Measurement of risk factors Sciences, Hamilton, ON, Canada, where quality-control
Structured questionnaires were administered and checks and statistical analysis were done.
physical examinations were done in the same manner in
cases and controls. Measurement of key vascular risk Statistical analysis
factors was consistent with the INTERHEART study13 The sample size for the INTERSTROKE study was based
and to phase 1 of INTERSTROKE.3 Further description of on an intention to include at least 1000 case-control pairs
risk-factor definitions is given in the appendix. The from all major regions in the world, to permit a globally
cutoffs used to divide participants into three tertiles for representative sample in the overall study and to provide
waist-to-hip ratio were 0·91 and 0·97 in men and 0·86 an estimate of association for common risk factors
and 0·93 in women. Hypertension was defined by self- within each region. The sample size was also determined
reported history of hypertension or the composite of self- to be adequate to detect an odds ratio (OR) of 1·2 or
reported hypertension or blood pressure of 140/90 mm Hg greater for minor allele frequencies of 0·1 for all stroke
or higher. To estimate preadmission blood pressure in and ischaemic stroke, and OR of 1·3 or greater for minor
cases, we used adjusted blood pressure readings on allele frequencies of 0·3 for each of the ischaemic and
hospital admission; the adjustment was based on data haemorrhagic stroke subtypes, assuming an additive
reported in the Oxford Vascular Study (OXVASC) and genetic model at genome-wide significance. The sample
Oxfordshire Community Stroke Project (OCSP) size was calculated on the basis of level of significance,
prospective cohort studies,14 which evaluated the two-sided test at α=0·01 for traditional risk factors and
relationship between premorbid blood pressure and α<5 × 10–⁸ for genetic markers (ie, genome-wide
acute post-stroke blood pressure (appendix pp 4, 15–16). significance); power (1–β) of 80%; and effect size (the
Our primary measure of blood pressure in cases was minimum OR considered to be clinically important,
adjusted blood pressure at the time of admission. Self- which is dependent upon the risk factor of interest). For
reported history of diabetes mellitus or HbA1c of 6·5% or example, to detect a minimum OR of 1·3 for allele
higher was used to define diabetes mellitus. Physically frequency of 0·3, we needed a sample size of 3000 case-
active individuals were defined as being regularly control pairs, which guided the sample size for
involved in moderate or strenuous leisure activity for 4 h intracerebral haemorrhage. The original assumptions
or more per week. Diet quality was defined by the underlying the sample size calculation for genetic risk
modified Alternative Healthy Eating Index (mAHEI); a factors were based on knowledge in 2007–08, at which
higher score indicates a healthier cardiovascular diet time an OR of 1·2 or 1·3 was considered plausible for
than does a low score.15,16 Smoking status was defined as common genetic variants.
never, former, or current smoker. Alcohol use was Means and medians were calculated to summarise
categorised into never or former, low intake, moderate continuous variables and were compared with t tests or
intake, and high (more than 14 drinks per week in appropriate non-parametric tests if distributional
women or more than 21 drinks per week in men) or assumptions were in doubt. Categorisation of data by
episodic heavy (more than five drinks in one episode at tertiles was based on the control data. We used
least once per month) intake.17 For psychosocial factors, conditional logistic regression (13 477 matched
Overall (n=13 447) Western Europe, Eastern and South America China South Asia Southeast Asia Africa (n=973)
North America, central Europe, (n=1471) (n=3987) (n=2850) (n=855)
Australia Middle East
(n=1917) (n=1394)
Age, years 62·2 66·7 63·9 65·8 61·9 59·6 56·6 58·7
(13·6) (13·4) (13·4) (14·3) (12·5) (12·9) (13·0) (15·2)
Age ≤45 years 1582 141 143 123 364 451 156 204
(11·8%) (7·4%) (10·3%) (8·4%) (9·1%) (15·8%) (18·3%) (21·0%)
Women 5434 781 556 652 1606 1017 352 470
(40·4%) (40·7%) (39·9%) (44·3%) (40·3%) (35·7%) (41·2%) (48·3%)
Intracerebral haemorrhage 3059 128 117 348 1102 785 285 294
(22·7%) (6·7%) (8·4%) (23·7%) (27·6%) (27·5%) (33·3%) (30·2%)
Ischaemic stroke 10 388 1789 1277 1123 2885 2065 570 679
(77·3%) (93·3%) (91·6%) (76·3%) (72·4%) (72·5%) (66·7%) (69·7%)
OCSP classification*
Total anterior circulation infarct 673/10 388 71/1789 72/1277 176/1123 127/2885 105/2065 33/570 89/679
(6·5%) (4·0%) (5·6%) (15·7%) (4·4%) (5·1%) (5·8%) (13·1%)
Partial anterior circulation infarct 4872/10 388 809/1789 631/1277 404/1123 1306/2885 945/2065 383/570 394/679
(46·9%) (45·2%) (49·4%) (36·0%) (45·3%) (45·8%) (67·2%) (58·0%)
Posterior circulation infarct 1509/10 388 353/1789 265/1277 146/1123 372/2885 258/2065 63/570 52/679
(14·5%) (19·7%) (20·8%) (13·0%) (12·9%) (12·5%) (11·1%) (7·7%)
Lacunar infarction 2789/10 388 536/1789 267/1277 212/1123 1051/2885 549/2065 79/570 95/679
(26·9%) (30·0%) (20·9%) (18·9%) (36·4%) (26·6%) (13·9%) (14·0%)
Undetermined 545/10 388 20/1789 42/1277 185/1123 29/2885 208/2065 12/570 49/679
(5·3%) (1·1%) (3·3%) (16·5%) (1·0%) (10·1%) (2·1%) (7·22%)
Modified Rankin scale score (1-month follow-up)
0–1 4907 900 596 376 1865 759 286 125
(36·5%) (47·0%) (42·8%) (25·6%) (46·8%) (26·6%) (33·5%) (12·9%)
2–3 5994 850 606 632 1638 1355 404 509
(44·6%) (44·3%) (43·5%) (43·0%) (41·1%) (47·5%) (47·3%) (52·3%)
4–5 1397 136 130 248 384 299 60 140
(10·4%) (7·1%) (9·3%) (16·9%) (9·6%) (10·5%) (7·0%) (14·4%)
6 1149 31 62 215 100 437 105 199
(8·5%) (1·6%) (4·5%) (14·6%) (2·5%) (15·3%) (12·3%) (20·5%)
Modified Rankin 3–6 5061 483 392 758 1169 1381 299 579
(37·6%) (25·2%) (28·1%) (51·5%) (29·3%) (48·5%) (35·0%) (59·5%)
CT or MRI of brain 13 441 1917 1394 1471 3987 2845 855 972
(99·9%) (100%) (100%) (100%) (100%) (99·8%) (100%) (99·9%)
Time to CT or MRI of brain, h† 8·61 7·98 4·24 8·89 4·86 7·95 9·36 30·64
(18·17) (13·71) (12·26) (16·73) (14·38) (14·83) (14·54) (35·08)
ECG 13 341 1908 1391 1442 3986 2820 855 939
(99·2%) (99·5%) (99·8%) (98·0%) (99·9%) (98·9%) (100%) (96·5%)
Vascular imaging*‡ 4155/10 354 1505/1786 829/1274 398/1104 1033/2885 311/2063 63/570 16/672
(40·1%) (84·3%) (65·1%) (36·1%) (35·8%) (15·1%) (11·1%) (2·4%)
Transthoracic echocardiography*‡ 1191/10 356 415/1787 259/1274 140/1106 280/2885 16/2061 9/570 72/673
(11·5%) (23·2%) (20·3%) (12·7%) (9·7%) (0·8%) (1·6%) (10·7%)
Holter monitor*‡ 750/10 356 442/1787 198/1274 67/1106 38/2885 2/2061 3/570 0/673
(7·2%) (24·7%) (15·5%) (6·1%) (1·3%) (0·1%) (0·5%)
Data are n (%) or mean (SD). Western Europe, North America, Australia includes Australia, Canada, Denmark, Germany, Sweden, UK, and Ireland. Eastern and central Europe, Middle East includes Croatia, Poland, Russia,
Turkey, Iran, Saudi Arabia, Kuwait, and United Arab Emirates. South America includes Argentina, Brazil, Chile, Colombia, Ecuador, and Peru. South Asia includes India and Pakistan. Southeast Asia includes Philippines,
Thailand, and Malaysia. Africa includes Mozambique, Nigeria, South Africa, Sudan, and Uganda. OCSP=Oxfordshire Community Stroke Project. ECG=electrocardiogram. *Percentages are calculated based on the totals from
ischaemic stroke. †Mean time for hospital admission to completion of CT or MRI of brain. ‡Diagnostic testing, where test was completed and report available at 1-month follow-up.
case-control pairs for primary analysis of all stroke), unconditional regression analyses were adjusted for age,
other than for subgroup analyses, for which we used sex, and geographical region, and all conditional analyses
unconditional logistic regression. We observed consistent were stratified on the matching criteria. In the
results between conditional and unconditional analyses, multivariable models, we sought to establish the
for analyses of potentially modifiable risk factors, association between common risk factors, identified in
including the entire cohort (appendix p 5). All the INTERHEART study and INTERSTROKE phase 1
studies (hypertension, smoking, diabetes mellitus, phase 1 of INTERSTROKE. More detailed description of
physical activity, diet, psychosocial factors, abdominal the analytical approach to estimating PARs was reported
obesity, alcohol, cardiac causes, and apolipoproteins), in the INTERHEART study report.13 Using this method,
and all stroke, ischaemic stroke, and intracerebral addition of PARs for individual risk factors usually
haemorrhage, for the entire cohort, by region, self- exceeds 100%, although the overall PAR for the composite
reported ethnic origin, sex, and age group. We included of these risk factors is less than 100%. An alternative
the entire INTERSTROKE population in analyses, but approach to estimating PAR, which ensures that adding
analysed the two phases of the study separately, to estimates for individual risk-factor multivariable
establish consistency of findings (appendix p 6). We estimates equals the PAR for the composite of these risk
collapsed several cardiac causes into one cardiac cause factors, is average PAR (APAR). Using this approach,
variable, because of the low prevalence of some cardiac described by Eide and Heuch,19 each risk factor is added
causes (other than atrial fibrillation) in the cohort, and to the model in every possible order (1–10), and the APAR
also reported on atrial fibrillation alone (which included for all risk factor permutations is calculated. To calculate
atrial flutter). To optimise power to detect associations, APAR, we used the method described by Ferguson and
we used the pool of controls for ischaemic stroke to colleagues.20 The advantage of this approach is that it
match additional controls to intracerebral haemorrhage allows measurement of the independent proportion of
cases, with a target ratio of 1:4 for case-control pairing. PAR that each risk factor contributes to the overall PAR
We used the same approach for ischaemic stroke (ie, for all risk factors. However, the disadvantage is that this
used an intracerebral haemorrhage control pool to approach might underestimate the effect of removing
increase the number of controls), with a target ratio of some individual risk factors on disease burden. All
1:2. Adjusted ORs for combinations of risk factors were statistical tests of hypotheses are two-sided. Statistical
derived from their model coefficients in the multivariable analyses and graphics were produced with SAS
logistic model. To find out whether individual vascular (version 9.2), R statistical program (version 3.2.4), and
risk factors were more significantly associated with TIBCO Spotfire S-Plus (version 8.2) for Windows.
ischaemic stroke than intracerebral haemorrhage, we did
a case-case analysis, which matched participants with Role of the funding source
ischaemic stroke to participants with intracerebral The funders of the study had no role in study design,
haemorrhage, matched for site, age, and sex. Estimates data collection, data analysis, data interpretation, or
of ORs and accompanying 99% CIs are presented for writing of the report. The corresponding author had full
every risk factor and their combinations, and the pinteraction access to all the data in the study and had final
value is reported for individual risk factors by region, sex, responsibility for the decision to submit for publication.
and age group. Our primary approach to univariate and
multivariable estimation of PAR for each risk factor, and Results
combination of risk factors, was the method described by 26 919 participants were recruited from 32 countries from
Benichou and Gail,18 and used in INTERHEART and Jan 11, 2007, to Aug 8, 2015, comprising 13 447 cases of
Prevalence in All stroke OR (99% CI) PAR, % (99% CI) Ischaemic stroke OR (99% CI) PAR, % (99% CI) Intracerebral OR (99% CI) PAR, % (99% CI)
controls (%) haemorrhage
Self-reported history of hypertension 35·4 2·56 (2·33 to 2·80) 34·4 (32·0 to 36·9) 2·34 (2·10 to 2·60) 32·0 (29·1 to 35·1) 3·71 (3·19 to 4·31) 42·8 (38·9 to 46·8)
Self-reported history of hypertension
or blood pressure ≥140/90 mm Hg 47·4 2·98 (2·72 to 3·28) 47·9 (45·1 to 50·6) 2·78 (2·50 to 3·10) 45·7 (42·4 to 49·0) 4·09 (3·51 to 4·77) 56·4 (52·0 to 60·6)
Current smoking 22·4 1·67 (1·49 to 1·87) 12·4 (10·2 to 14·9) 1·93 (1·69 to 2·21) 15·1 (12·8 to 17·8) 1·14 (0·95 to 1·36) 3·6 (0·9 to 13·0)
Waist-to-hip ratio
T2 vs T1 34·1 1·24 (1·11 to 1·39) 1·31 (1·14 to 1·49) 1·16 (0·98 to 1·38)
T3 vs T1 32·9 1·44 (1·27 to 1·64) 18·6 (13·3 to 25·3) 1·44 (1·25 to 1·67) 20·4 (14·3 to 28·2) 1·33 (1·09 to 1·62) 13·1 (6·4 to 25·1)
Diet (mAHEI score)
T2 vs T1 34·0 0·77 (0·69 to 0·86) 0·75 (0·66 to 0·85) 0·80 (0·68 to 0·94)
T3 vs T1 33·0 0·60 (0·53 to 0·67) 23·2 (18·2 to 28·9) 0·59 (0·52 to 0·68) 22·4 (17·0 to 29·0) 0·61 (0·50 to 0·74) 24·5 (16·5 to 34·8)
Regular physical activity 16·3 0·60 (0·52 to 0·70) 35·8 (27·7 to 44·7) 0·63 (0·53 to 0·74) 33·4 (24·2 to 44·0) 0·63 (0·48 to 0·81) 34·6 (21·3 to 50·7)
Self-reported history of diabetes or 22·0 1·16 (1·05 to 1·30) 3·9 (1·9 to 7·6) 1·33 (1·18 to 1·50) 7·5 (5·0 to 11·1) 0·72 (0·60 to 0·87) –7·0 ( –11 to –3·0)
HbA1c ≥6·5%
Alcohol
Low or moderate 25·2 1·14 (1·01 to 1·28) 1·07 (0·93 to 1·23) 1·43 (1·17 to 1·74)
High or heavy episodic 2·5 2·09 (1·64 to 2·67) 5·8 (3·4 to 9·7) 2·14 (1·62 to 2·82) 4·6 (2·0 to 10·0) 2·44 (1·64 to 3·63) 9·8 (6·4 to 14·8)
Psychosocial factors ·· 2·20 (1·78 to 2·72) 17·4 (13·1 to 22·6) 1·98 (1·56 to 2·52) 15·1 (10·3 to 21·5) 2·84 (1·98 to 4·08) 24·7 (18·1 to 32·8)
Cardiac causes 5·0 3·17 (2·68 to 3·75) 9·1 (8·0 to 10·2) 3·49 (2·91 to 4·18) 11·4 (10·1 to 12·8) 1·58 (1·09 to 2·28) 1·4 (0·6 to 3·4)
ApoB/ApoA1 ratio
T2 vs T1 34·0 1·28 (1·14 to 1·42) 1·41 (1·24 to 1·60) 0·94 (0·79 to 1·11)
T3 vs T1 33·0 1·84 (1·65 to 2·06) 26·8 (22·2 to 31·9) 2·19 (1·92 to 2·49) 34·0 (29·0 to 39·3) 1·10 (0·92 to 1·31) 1·2 (0·0 to 98·3)
Composite PAR* 90·7 (88·7 to 92·4) 91·5 (89·4 to 93·2) 87·1 (82·2 to 90·8)
0·1 0·2 0·5 1·0 2·0 5·0 10·0 0·1 0·2 0·5 1·0 2·0 5·0 10·0 0·1 0·2 0·5 1·0 2·0 5·0 10·0
OR (99% CI) OR (99% CI) OR (99% CI)
Figure 1: Multivariable analysis of prevalence of risk factors, OR, and PAR for ten risk factors
Cardiac sources include atrial fibrillation or flutter, previous myocardial infarction, rheumatic valve disease, or prosthetic heart valve. For tertiles, PAR was calculated using T2 +T3 versus T1, other than diet,
where PAR was calculated using T1+T2 versus T3. For physical activity, OR is reported for physically active versus other, and PAR is calculated for the inverse. For alcohol, OR is reported for high or heavy
episodic, low or moderate vs former or never drinker, PAR is reported for current alcohol intake vs former or never drinker. For psychosocial factors, additional adjustment for education and income
(purchasing power parity) reported a PAR 16·1% (99% CI 11·6–21·9) for all stroke. Apo=apolipoprotein. mAHEI=modified Alternative Healthy Eating Index. OR=odds ratio. PAR=population attributable
risk. T=tertile. *Composite PAR includes all ten risk factors; self-reported history of hypertension or blood pressure ≥140/90 mm Hg was used for hypertension variable.
A Hypertension Prevalence in All OR (99% CI) PAR, % (99% CI) Ischaemic OR (99% CI) PAR, % (99% CI) Intracerebral OR (99% CI) PAR, % (99% CI)
controls (%) stroke stroke haemorrhage
Western Europe, North America, Australia (n=3836) 56·1 2·08 (1·59 to 2·72) 38·8 (28·7 to 50·0) 2·21 (1·66 to 2·94) 41·3 (31·1 to 52·3) 1·61 (0·78 to 3·31) 25·2 (5·9 to 64·6)
Eastern and central Europe, Middle East (n=2787) 58·8 2·20 (1·61 to 3·00) 42·1 (30·6 to 54·4) 2·11 (1·52 to 2·95) 40·7 (28·3 to 54·3) 3·76 (1·54 to 9·22) 56·3 (29·4 to 79·9)
South America (n=2959) 63·4 2·38 (1·73 to 3·28) 46·3 (34·8 to 58·2) 2·19 (1·53 to 3·15) 43·3 (29·7 to 58·0) 3·05 (1·64 to 5·67) 54·1 (34·0 to 72·9)
China (n=7974) 40·3 3·34 (2·86 to 3·90) 49·0 (44·9 to 53·2) 3·07 (2·55 to 3·70) 46·0 (41·0 to 51·1) 4·78 (3·77 to 6·06) 59·0 (52·7 to 65·0)
Southeast Asia (n=1710) 54·9 3·78 (2·44 to 5·85) 59·6 (47·8 to 70·3) 3·23 (1·93 to 5·39) 54·8 (40·2 to 68·6) 4·87 (2·57 to 9·22) 67·2 (50·8 to 80·3)
South Asia (n=5704) 36·4 3·81 (3·00 to 4·83) 47·2 (41·9 to 52·5) 3·61 (2·71 to 4·80) 45·5 (39·2 to 52·0) 4·37 (3·19 to 5·99) 51·4 (43·2 to 59·5)
Africa (n=1949) 43·5 4·01 (2·59 to 6·21) 52·5 (43·1 to 61·6) 3·39 (1·97 to 5·84) 46·1 (32·3 to 58·4) 6·13 (3·24 to 11·6) 67·0 (53·0 to 78·5)
All (n=26 919) 47·4 2·98 (2·72 to 3·28) 47·9 (45·1 to 50·6) 2·78 (2·50 to 3·10) 45·7 (42·4 to 49·0) 4·09 (3·51 to 4·77) 56·4 (52·0 to 60·6)
B Current smoking
Western Europe, North America, Australia (n=3836) 10·5 2·97 (2·08 to 4·23) 18·0 (14·1 to 22·6) 3·31 (2·28 to 4·81) 19·5 (15·6 to 24·1) 1·08 (0·39 to 3·01) 1·2 (0·0 to 100·0)
Eastern and central Europe, Middle East (n=2787) 18·9 1·86 (1·31 to 2·63) 13·2 (8·2 to 20·7) 2·02 (1·39 to 2·92) 14·7 (9·5 to 22·2) 0·88 (0·38 to 2·07) –3·0 (–23·3 to 17·7)
South America (n=2959) 9·7 1·69 (1·09 to 2·62) 6·2 (3·0 to 12·3) 2·11 (1·27 to 3·48) 8·4 (4·7 to 14·4) 1·08 (0·50 to 2·33) 0·9 (0·0 to 99·2)
China (n=7974) 30·2 1·65 (1·35 to 2·02) 15·0 (10·6 to 20·8) 2·02 (1·59 to 2·58) 20·3 (15·3 to 26·3) 1·05 (0·78 to 1·40) 1·4 (0·0 to 91·0)
Southeast Asia (n=1710) 25·7 1·38 (0·86 to 2·20) 9·2 (2·6 to 27·9) 1·68 (0·94 to 3·03) 13·2 (5·1 to 30·0) 1·15 (0·59 to 2·21) 4·5 (0·0 to 82·1)
South Asia (n=5704) 30·8 1·27 (0·97 to 1·67) 8·0 (2·8 to 21·1) 1·32 (0·95 to 1·83) 8·8 (3·0 to 23·0) 1·35 (0·93 to 1·95) 10·4 (3·2 to 29·1)
Africa (n=1949) 10·7 1·64 (0·87 to 3·07) 4·5 (1·3 to 14·2) 1·59 (0·71 to 3·55) 4·1 (0·8 to 18·7) 1·31 (0·59 to 2·94) 3·1 (0·2 to 35·2)
All (n=26 919) 22·4 1·67 (1·49 to 1·87) 12·4 (10·2 to 14·9) 1·93 (1·69 to 2·21) 15·1 (12·8 to 17·8) 1·14 (0·95 to 1·36) 3·6 (0·9 to 13·0)
C Waist-to-hip ratio
Western Europe, North America, Australia (n=3836) 34·8 2·14 (1·53 to 2·99) 36·7 (24·9 to 50·4) 2·24 (1·57 to 3·18) 38·5 (26·3 to 52·2) 1·61 (0·60 to 4·34) 33·9 (7·3 to 77·0)
Eastern and central Europe, Middle East (n=2787) 42·5 1·16 (0·80 to 1·69) 2·8 (0·0 to 99·7) 1·22 (0·83 to 1·80) 7·2 (0·2 to 77·3) 0·75 (0·29 to 1·94) –33·0 (–12·4 to 57·4)
South America (n=2959) 40·8 1·89 (1·32 to 2·71) 20·9 (7·8 to 45·2) 1·66 (1·10 to 2·50) 17·2 (3·8 to 52·0) 2·08 (1·14 to 3·79) 13·2 (0·8 to 73·1)
China (n=7974) 22·7 1·16 (0·91 to 1·47) 7·8 (1·9 to 16·5) 1·17 (0·88 to 1·57) 11·0 (3·2 to 31·5) 1·13 (0·81 to 1·59) 1·8 (0·0 to 97·9)
Southeast Asia (n=1710) 48·9 1·54 (0·81 to 2·96) 37·2 (12·0 to 71·9) 1·52 (0·71 to 3·24) 39·2 (12·9 to 73·7) 1·90 (0·74 to 4·90) 44·7 (11·3 to 83·6)
South Asia (n=5704) 33·9 1·67 (1·17 to 2·38) 32·1 (12·1 to 45·4) 1·47 (0·95 to 2·28) 28·2 (14·4 to 47·8) 1·42 (0·88 to 2·28) 28·1 (14·6 to 47·1)
Africa (n=1949) 29·8 1·56 (0·94 to 2·62) 24·2(10·1 to 47·5) 1·43 (0·76 to 2·69) 24·5 (7·9 to 55·1) 1·42 (0·72 to 2·78) 21·5 (4·4 to 61·8)
All (n=26 919) 32·9 1·44 (1·27 to 1·64) 18·6 (13·3 to 25·3) 1·44 (1·25 to 1·67) 20·4 (14·3 to 28·2) 1·33 (1·09 to 1·62) 13·1 (6·4 to 25·1)
D Diet (mAHEI)
Western Europe, North America, Australia (n=3836) 49·4 0·44 (0·33 to 0·60) 33·3 (24·3 to 43·7) 0·46 (0·33 to 0·63) 31·3 (21·8 to 42·7) 0·25 (0·11 to 0·60) 50·7 (30·1 to 71·1)
Eastern and central Europe, Middle East (n=2787) 41·6 0·53 (0·37 to 0·77) 26·5 (15·2 to 42·0) 0·57 (0·39 to 0·83) 23·7 (11·9 to 41·8) 0·52 (0·20 to 1·32) 29·5 (6·4 to 72·0)
South America (n=2959) 33·9 0·49 (0·35 to 0·70) 37·3 (25·5 to 50·8) 0·50 (0·34 to 0·74) 35·8 (23·1 to 50·8) 0·44 (0·24 to 0·81) 48·2 (29·0 to 67·9)
China (n=7974) 25·5 0·48 (0·38 to 0·62) 30·4 (20·8 to 42·0) 0·48 (0·36 to 0·64) 28·5 (17·6 to 42·7) 0·44 (0·31 to 0·62) 39·3 (25·8 to 54·7)
Southeast Asia (n=1710) 37·1 0·50 (0·30 to 0·82) 26·0 (10·1 to 52·2) 0·45 (0·24 to 0·84) 28·7 (11·4 to 55·8) 0·45 (0·22 to 0·93) 30·8 (8·0 to 69·5)
South Asia (n=5704) 29·3 1·62 (1·15 to 2·28) –28·0 (–54·4 to –2·0) 1·67 (1·10 to 2·53) –31·0 (–63·2 to 1·4) 1·11 (0·75 to 1·63) –0·3 (–20·0 to 19·3)
Africa (n=1949) 25·0 0·78 (0·49 to 1·25) 0·7 (0·0 to 100·0) 0·79 (0·44 to 1·40) –6·7 (–45·0 to 31·6) 1·03 (0·54 to 1·95) –10·0 (–58·1 to 37·5)
All (n=26 919) 33·0 0·60 (0·53 to 0·67) 23·2 (18·2 to 28·9) 0·59 (0·52 to 0·68) 22·4 (17·0 to 29·0) 0·61 (0·50 to 0·74) 24·5 (16·5 to 34·8)
F Alcohol intake
Western Europe, North America, Australia (n=3836) 5·7 1·59 (0·94 to 2·69) –3·8 (–23·5 to 16·0) 1·66 (0·96 to 2·88) –1·2 (–21·1 to 18·7) 0·99 (0·21 to 4·73) –32·0% (–104·0 to 40.9)
Eastern and central Europe, Middle East (n=2787) 1·4 2·17 (0·78 to 6·05) 1·8 (0·0 to 82·7) 2·36 (0·81 to 6·87) 2·1 (0·0 to 75·4) 1·69 (0·04 to 77·6) 1·7 (0·0 to 100·0)
South America (n=2959) 1·0 2·90 (0·93 to 9·07) 6·6 (2·4 to 17·1) 2·70 (0·73 to 10·0) 1·7 (0·0 to 79·1) 7·23 (0·94 to 55·6) 16·2 (9·3 to 26·6)
China (n=7974) 3·4 1·77 (1·22 to 2·57) 2·6 (0·4 to 15·3) 1·74 (1·13 to 2·69) 0·7 (0·0 to 98·2) 2·19 (1·27 to 3·75) 6·2 (2·1 to 16·6)
Southeast Asia (n=1710) 2·1 2·14 (0·51 to 9·00) 4·6 (0·1 to 67·6) 2·27 (0·47 to 11·0) 4·2 (0·1 to 79·1) 1·06 (0·04 to 25·8) 8·0 (0·2 to 80·0)
South Asia (n=5704) 1·1 2·77 (1·19 to 6·44) 10·7 (7·4 to 15·4) 4·18 (1·33 to 13·2) 11·0 (7·2 to 16·6) 2·80 (0·96 to 8·13) 10·3 (5·3 to 18·8)
Africa (n=1949) 1·1 5·91 (1·44 to 24·3) 10·4 (4·3 to 22·8) 7·75 (1·11 to 54·2) 5·1 (0·7 to 30·5) 5·30 (1·14 to 24·6) 23·7 (12·7 to 39·8)
All (n=26 919) 2·5 2·09 (1·64 to 2·67) 5·8 (3·4 to 9·7) 2·14 (1·62 to 2·82) 4·6 (2·0 to 10·0) 2·44 (1·64 to 3·63) 9·8 (6·4 to 14·8)
0·1 0·2 0·5 1·0 2·0 5·0 10·0 0·1 0·2 0·5 1·0 2·0 5·0 10·0 0·1 0·2 0·5 1·0 2·0 5·0 10·0
OR (99% CI) OR (99% CI) OR (99% CI)
acute first-ever stroke and 13 472 controls (403 [3·0%] of completed by patients (5573 [41·4%]), proxy respondents
controls had chronic bronchitis, 948 [7·0%] had malaria, (4953 [36·8%]), or both together (2917 [21·7%]); missing
263 [2·0%] had tuberculosis, 127 [0·9%] had venous for four participants. Descriptive characteristics of cases
thrombosis, and 107 [0·8%] had peripheral vascular are reported in table 1. The proportion of patients
disease; appendix p 14). Neuroimaging was completed in undergoing diagnostic testing, to identify a source of
13 441 (99·9%) of 13 447 cases. Questionnaires were thromboembolism, varied between regions (table 1). The
A Apolipoproteins (Apo) B/A1 Prevalence in All OR (99% CI) PAR, % (99% CI) Ischaemic OR (99% CI) PAR, % (99% CI) Intracerebral OR (99% CI) PAR, % (99% CI)
controls (%) stroke stroke haemorrhage
Western Europe, North America, Australia (n=3836) 27·6 1·83 (1·33 to 2·52) 24·3 (12·8 to 41·2) 1·86 (1·33 to 2·60) 24·8 (13·0 to 42·1) 1·54 (0·64 to 3·70) 23·0 (1·9 to 82·4)
Eastern and central Europe, Middle East (n=2787) 45·4 2·73 (1·84 to 4·05) 49·7 (35·1 to 64·3) 2·62 (1·73 to 3·97) 48·2 (38·7 to 64·0) 2·71 (0·87 to 8·49) 45·9 (9·6 to 87·1)
South America (n=2959) 45·3 1·76 (1·21 to 2·57) 33·2 (17·5 to 53·9) 1·77 (1·16 to 2·70) 34·3 (17·2 to 56·6) 1·17 (0·59 to 2·29) 9·3 (0·0 to 97·6)
China (n=7974) 18·3 1·59 (1·31 to 1·94) 16·9 (10·9 to 25·2) 2·06 (1·63 to 2·60) 26·4 (19·4 to 34·9) 0·82 (0·60 to 1·10) –9·2 (–21·2 to 2·8)
Southeast Asia (n=1710) 42·8 4·86 (2·75 to 8·58) 66·7 (49·7 to 80·1) 5·25 (2·63 to 10·5) 67·6 (46·9 to 83·1) 4·53 (1·97 to 10·4) 66·7 (42·3 to 84·5)
South Asia (n=5704) 42·7 1·52 (1·15 to 2·01) 20·4 (9·2 to 39·4) 2·10 (1·47 to 2·98) 33·9 (20·3 to 50·9) 0·86 (0·59 to 1·25) –7·5 (–34·2 to 19·3)
Africa (n=1949) 42·8 2·51 (1·52 to 4·15) 44·6 (25·8 to 65·0) 2·80 (1·51 to 5·17) 48·3 (26·9 to 70·3) 1·70 (0·86 to 3·37) 26·8 (6·5 to 65·7)
All (n=26 919) 33·0 1·84 (1·65 to 2·06) 26·8 (22·2 to 31·9) 2·19 (1·92 to 2·49) 34·0 (29·0 to 39·3) 1·10 (0·92 to 1·31) 1·2 (0·0 to 98·3)
Western Europe, North America, Australia (n=3836) 15·5 1·12 (0·82 to 1·52) 2·4 (0·2 to 27·4) 1·17 (0·85 to 1·61) 3·5 (0·5 to 20·4) 0·47 (0·16 to 1·35) –13·0 (–33·2 to 7·9)
Eastern and central Europe, Middle East (n=2787) 26·0 1·20 (0·89 to 1·63) 5·6 (1·0 to 25·2) 1·31 (0·95 to 1·79) 8·0 (2·4 to 23·5) 0·74 (0·32 to 1·71) –8·4 (–31·6 to 14·8)
South America (n=2959) 26·0 1·13 (0·84 to 1·52) 3·4 (0·3 to 30·8) 1·19 (0·84 to 1·68) 5·2 (0·7 to 28·6) 1·19 (0·69 to 2·05) 3·6 (0·1 to 52·0)
China (n=7974) 11·9 1·34 (1·08 to 1·66) 4·4 (2·2 to 8·5) 1·68 (1·31 to 2·16) 8·4 (5·5 to 12·7) 0·57 (0·39 to 0·83) –5·7 (–9·5 to –1·8)
Southeast Asia (n=1710) 39·4 1·53 (0·97 to 2·40) 17·4 (6·3 to 39·8) 1·94 (1·13 to 3·32) 28·6 (14·0 to 49·8) 0·72 (0·38 to 1·35) –12·0 (–35·3 to 10·9)
South Asia (n=5704) 33·3 1·00 (0·78 to 1·28) –0·1 (–10·0 to 9·8) 1·16 (0·86 to 1·56) 5·8 (0·8 to 32·6) 0·77 (0·56 to 1·07) –9·5 (–21·4 to 2·5)
Africa (n=1949) 15·7 1·46 (0·89 to 2·40) 7·8 (2·4 to 22·5) 1·70 (0·93 to 3·10) 11·3 (4·2 to 26·9) 0·90 (0·46 to 1·77) –2·0 (–15·2 to 11·2)
All (n=26 919) 22·0 1·16 (1·05 to 2·30) 3·9 (1·9 to 7·6) 1·33 (1·18 to 1·50) 7·5 (5·0 to 11·1) 0·72 (0·60 to 0·87) –7·0 (–11·1 to –3·0)
C Psychosocial factors
Western Europe, North America, Australia (n=3836) 1·19 (0·72 to 1·96) 2·6 (0·0 to 88·7) 1·07 (0·64 to 1·80) –1·0 (–17·0 to 15·0) 1·99 (0·48 to 8·20) 20·5 (2·7 to 70·6)
Eastern and central Europe, Middle East (n=2787) 1·72 (0·96 to 3·08) 15·3 (5·0 to 38·2) 1·58 (0·86 to 2·90) 12·3 (2·8 to 40·5) 4·68 (0·86 to 25·6) 45·4 (17·2 to 76·8)
South America (n=2959) 1·88 (1·07 to 3·30) 17·3 (4·4 to 48·5) 1·61 (0·86 to 3·02) 10·9 (1·0 to 58·9) 2·35 (0·87 to 6·37) 36·1 (10·6 to 72·9)
China (n=7974) 5·79 (3·39 to 9·87) 30·6 (25·8 to 35·9) 6·27 (3·28 to 12·0) 30·1 (24·3 to 36·5) 5·12 (2·39 to 11·0) 32·3 (25·2 to 40·4)
Southeast Asia (n=1710) 1·63 (0·57 to 4·65) 9·8 (0·2 to 84·1) 1·97 (0·57 to 6·80) 11·5 (0·4 to 80·7) 1·40 (0·32 to 6·08) 26·9 (2·8 to 82·4)
South Asia (n=5704) 3·47 (1·90 to 6·35) 8·1 (1·3 to 36·9) 4·11 (2·03 to 8·32) 15·3 (5·3 to 36·9) 2·00 (0·86 to 4·66) 3·0 (0·0 to 94·8)
Africa (n=1949) * * * * * *
All (n=26 919) 2·20 (1·78 to 2·72) 17·4 (13·1 to 22·6) 1·98 (1·56 to 2·52) 15·1 (10·3 to 21·5) 2·84 (1·98 to 4·08) 24·7 (18·1 to 32·8)
D Cardiac causes
Western Europe, North America, Australia (n=3836) 12·4 2·81 (2·07 to 3·81) 19·7 (15·5 to 24·7) 2·92 (2·12 to 4·01) 20·6 (16·2 to 25·7) 1·82 (0·73 to 4·57) 8·7 (1·5 to 36·7)
Eastern and central Europe, Middle East (n=2787) 11·3 3·18 (2·21 to 4·59) 20·3 (15·7 to 25·8) 3·37 (2·30 to 4·95) 21·5 (16·7 to 27·2) 2·07 (0·74 to 5·80) 9·2 (2·0 to 33·7)
South America (n=2959) 8·9 2·19 (1·44 to 3·32) 9·5 (6·0 to 14·7) 2·65 (1·69 to 4·16) 13·6 (9·3 to 19·5) 0·87 (0·31 to 2·44) –0·6 (–5·5 to 4·2)
China (n=7974) 1·4 3·49 (2·19 to 5·57) 3·7 (2·7 to 5·0) 4·03 (2·40 to 6·77) 4·9 (3·6 to 6·5) 1·35 (0·58 to 3·14) 0·4 (0·0 to 7·6)
Southeast Asia (n=1710) 2·6 10·1 (3·61 to 28·0) 8·1 (5·5 to 11·7) 9·70 (3·32 to 28·3) 10·3 (6·9 to 15·1) 2·09 (0·48 to 9·18) 1·8 (0·2 to 15·1)
South Asia (n=5704) 1·3 7·21 (3·44 to 15·1) 5·2 (3·9 to 7·0) 9·70 (3·96 to 23·7) 6·4 (4·7 to 8·5) 3·23 (1·14 to 9·16) 2·3 (0·9 to 5·8)
Africa (n=1949) 2·6 3·64 (1·60 to 8·31) 7·0 (4·2 to 11·5) 3·80 (1·45 to 9·95) 8·8 (5·1 to 14·8) 2·35 (0·55 to 9·96) 2·5 (0·4 to 14·0)
All (n=26 919) 5·0 3·17 (2·68 to 3·75) 9·1 (8·0–10·2) 3·49 (2·91 to 4·18) 11·4 (10·1 to 12·8) 1·58 (1·09 to 2·28) 1·4 (0·6 to 3·4)
0·1 0·2 0·5 1·0 2·0 5·0 10·0 0·1 0·2 0·5 1·0 2·0 5·0 10·0
OR (99% CI) OR (99% CI)
Western Europe, North America, Australia (n=3581) 7·4 4·05 (2·74 to 5·98) 17·1 (13·8 to 21·1)
Eastern and central Europe and Middle East (n=2529) 5·4 4·05 (2·55 to 6·44) 16·2 (12·5 to 20·8)
South America (n=2262) 4·8 3·96 (2·23 to 7·04) 11·2 (8·0 to 15·4)
China (n=5770) 0·9 6·98 (3·46 to 14·1) 4·5 (3·4 to 5·9)
Southeast Asia (n=1140) 1·9 10·70 (3·12 to 36·8) 8·5 (5·4 to 12·9)
South Asia (n=3864) 1·2 5·75 (2·03 to 16·2) 3·1 (1·9 to 5·0)
Africa (n=1364) 2·0 4·37 (1·42 to 13·5) 7·9 (4·5 to 13·5)
All (n=20 510) 3·2 4·59 (3·66 to 5·75) 9·0 (8·0 to 10·1)
A Wald test was used to test for interaction between risk factor × sex for all stroke, and pinteraction was significant (p<0·01) for waist-to-hip ratio, and cardiac causes using logistic
regression. Apo=apolipoprotein. mAHEI=modified Alternative Healthy Eating Index. OR=odds ratio. PAR=population attributable risk. T=tertile.
Table 3: Risk factors for all stroke (ischaemic and intracerebral haemorrhage) in men and women
psychosocial factors, and cardiac causes in the subgroup was associated with an OR of 0·65 (99% CI 0·57–0·72), and
analysis of community-based controls than in the analysis a PAR of 26·7% (21·2–32·9) for all stroke. Using the
of hospital-based controls. Collectively, the composite American Heart Association (AHA) recommendation (2·5 h
PAR for all ten risk factors was 92·1% (99% CI 89·8–93·9) or more of exercise per week), physical activity was associated
for community-based controls and 87·8% (83·2–91·2) on with a reduction in all stroke (OR 0·41 [0·35–0·48],
conditional regression analyses (appendix p 12). PAR 53·0% [47·0–59·0]). Body-mass index was associated
Using adjusted blood pressure at the time of interview for with a weaker magnitude of association than waist-to-hip
cases, we observed a consistent association between self- ratio (figure 4). When we re-categorised alcohol intake into
reported hypertension or blood pressure of 140/90 mm Hg moderate, high, or heavy episodic intake (seven or more
or higher and all stroke (OR 2·62 [99% CI 2·39–2·87], drinks per week), we found an association between alcohol
PAR 43·3% [40·4–46·2]). Additional estimates for alternative intake and all stroke (OR 1·46 [1·26–1·69], PAR 4·3%
definition of hypertension are reported in the appendix (p 4). [3·0–6·0]). Number of cigarettes smoked per day was
Replacing mAHEI with daily intake of fruit and vegetables associated with a graded increase in risk of stroke (figure 5).
A Wald test was used to test for interaction between risk factor × age subgroup for all stroke, and pinteraction was significant (p<0·01) for hypertension, waist-to-hip ratio, diet,
and cardiac causes using logistic regression. Apo=apolipoprotein. mAHEI=modified Alternative Healthy Eating Index. OR=odds ratio. PAR=population attributable risk.
T=tertile.
Table 4: Risk factors for all stroke (ischaemic and intracerebral haemorrhage) by age group
Compared with our primary analysis of PAR estimates, international population, but phase 1 was of insufficient
results from the APAR analysis showed a lower estimate scope to report estimates by regions or in key populations.
for individual risk factors, but a similar estimate for In this full-scale study (which includes phases 1 and 2 of
combination of all ten risk factors (APAR 89·1% [99% CI the INTERSTROKE study), we provide more robust and
87·2 to 90·9] for all stroke) and generally preserved the reliable estimates for the contribution of these ten
relative importance of individual risk factors (appendix potentially modifiable risk factors in a larger population
p 13). (n=26 919), with representation from all major regions of
the world (32 countries). We report that ten potentially
Discussion modifiable, and common, risk factors were associated
In the first phase of the INTERSTROKE study (n=6000),3 with about 90% of the PAR for stroke in all regions,
we reported preliminary estimates of the association of thereby extending the generalisability of our findings
common risk factors with the PAR for stroke in an from phase 1. However, we found evidence of regional and
26·8% in INTERSTROKE vs 4·5% in GBD), which Figure 4: BMI and WHR association with risk of all stroke
probably relates to our use of apolipoprotein ratio rather BMI=body-mass index. WHR=waist-to-hip ratio.
than total cholesterol, which has been shown to have a
weaker association with stroke risk,3,21 and we report a 8·0 All stroke Ischaemic stroke Intracerebral haemorrhage
larger magnitude of association for physical inactivity (PAR
35·8% vs 7·7%). By contrast with the GBD meta-analysis,
estimates from the INTERSTROKE study are based on
standardised methods of measuring each risk factor and 4·0
determination of stroke, which is expected to provide more
reliable estimates of association, and comparisons between
Odds ratio (99% CI)
proportion of the population in south Asia are vegetarian 55 years or younger (PAR 49·7%) and people older than
(about 40%), and there is evidence of high use of 55 years (PAR 46·0%), and in men (PAR 45·2%) and
hydrogenated vegetable oil-based ghee in cooking and women (PAR 52·3%), suggesting that a large proportion
transition away from whole plant foods, which might of the global burden of stroke might be preventable
contribute to this finding.25 Although additional research through control of blood pressure, with population-level
is needed to confirm these findings, the results from this interventions.40
study raise caution about the generalisability of diet risk Our study provides further information that clarifies
scores developed in North America and Europe to other differences in association of risk factors with ischaemic
regions. Other than diet, the direction of association for stroke and intracerebral haemorrhage (figure 1, appendix
all other risk factors was generally consistent across p 7).41 Seven risk factors were common to both ischaemic
regions, although the magnitude of OR varied by region stroke and intracerebral haemorrhage, of which
for many risk factors. For example, we found evidence of hypertension was significantly more strongly associated
regional variations in the association between alcohol with intracerebral haemorrhage than with ischaemic
consumption and stroke, which was also observed in the stroke. Smoking, diabetes mellitus, and apolipoproteins
PURE study,17 and for acute myocardial infarction in the were significant risk factors for ischaemic stroke, but not
INTERHEART study,26 which might relate to variations for intracerebral haemorrhage. Therefore, although a
in patterns and types of alcohol consumed. We also broader array of targets exists for prevention of ischaemic
observed a graded reduction in OR for hypertension stroke than for intracerebral haemorrhage, a more
from high-income regions to low-income regions, which marked reduction in intracerebral haemorrhage is
could relate to known differences in detection and expected by the reduction of blood pressure alone.42 Our
management of hypertension,27 but perhaps also to study suggests that the mix of stroke subtypes in a
differences in magnitude of association by ethnic population is probably influenced by variations in the
origin.28,29 Other examples include a higher OR for prevalence of vascular risk factors, which could account
apolipoproteins in southeast Asia and psychosocial for some of the worldwide variations in pattern of stroke
factors in China than in other regions. Inter-regional subtypes.1,2,6
variations in PAR were also related to differences in risk- Investigators of the PURE study43 found regional
factor prevalence. Atrial fibrillation was associated with variations in the pattern of cardiovascular disease events.
an OR of more than 3·0 for ischaemic stroke in all Stroke accounts for a larger proportion of all cardio
regions, but PAR ranged from 3·1% in south Asia to vascular disease events in Asia than in North America or
17·1% in western Europe, North America, and Australia. Europe. Although an indirect comparison of our findings
The range of PARs noted were mostly due to variations with INTERHEART13 shows commonality of risk factors
in the prevalence of atrial fibrillation, and there is some for acute stroke and acute myocardial infarction, the
evidence to support regional variations in prevalence of relative magnitude of association for each risk factor
atrial fibrillation in patients with acute ischaemic stroke, seems to be different, which might contribute to
based on indirect comparisons of studies.30–33 Some worldwide variations in patterns of cardiovascular
variations in the prevalence of atrial fibrillation relate to disease.
differences in mean age of participants by region (eg, In our primary analysis, the sum of PARs for each
mean age in western Europe, North America, and individual risk factor exceeded the PAR reported for
Australia is 7–10 years higher than south Asia, southeast composite risk factors (90·7% for all stroke), which is a
Asia, and Africa), but might also relate to reported characteristic of the PAR metric. Like myocardial
differences in prevalence of atrial fibrillation by infarction, stroke is a consequence of numerous causal
geographic region and ethnic origin.34,35 High alcohol risk factors, rather than a single cause, with the arguable
intake and smoking were more prevalent in men than exception of severe hypertension for intracerebral
women, but had a similar OR, resulting in a different haemorrhage. Generally, multiple risk factors are needed
PAR for men and women, which has been reported in to act together to be sufficient to cause an acute stroke.
other studies.17,36 Therefore, targeted interventions to Therefore, the proportion of disease that can be attributed
screen and manage these risk factors are expected to to each of the causal mechanisms of stroke disease can
have consistent relative reductions in risk across add up to more than 100%,44 as observed in our analyses.
populations, but different effects on incidence of stroke We explored an alternative method to estimate PAR,
across regions and in men and women. Overall, however, average PAR, which requires the sum of individual PARs
our findings show more consistency than differences to equal the overall PAR for the composite of risk
among regions and subgroup populations. Hypertension factors.19,20 In that analysis, we found a lower APAR,
is the most important target for stroke prevention compared with PAR, for all individual risk factors, which
worldwide, associated with PARs ranging from is expected, with preservation of the relative ranking of
38·8% to 59·6% in all regions, which is generally importance (appendix p 13). PAR and APAR do not
consistent with estimates from other studies.8,37–39 provide conflicting information, but a different
Hypertension is similarly important in people aged perspective on the contribution of common risk factors.
PAR provides a better estimate of the potential effect of with vascular risk factors (eg, smoking and chronic
complete removal of an individual risk factor on disease obstructive pulmonary disease). However, the prevalence
burden than APAR, whereas APAR might better reflect of measured comorbidities was similar in cases and
anticipated effects when multiple risk factors are modified controls (appendix p 14). Inclusion of some hospital
simultaneously. controls could have increased the prevalence of diabetes in
Our study has a few limitations, some of which have controls, which might have contributed to the lower PAR
been previously reported in the phase 1 study report.3 A reported in our study compared with other studies,8,37
case-control study design is potentially open to bias if the although estimates for Asia are similar to those reported by
method of ascertaining risk factors is different between Huxley and colleagues.36 Overall, the prevalence of most
cases and controls. Measurement of some risk factors in risk factors in controls seems consistent with estimates of
cases could be misclassified if an acute stroke changes the these risk factors from the PURE study;27,43 for example, the
level of a risk factor. This can be particularly problematic prevalence of hypertension was 47·4% in INTERSTROKE
for blood pressure after stroke, and can be a greater source versus 40·8% in PURE and, for current smoking, 22·4%
of error for intracerebral haemorrhage than ischaemic versus 20·9%.
stroke. We gave this issue careful consideration, because Finally, a causal association between risk factors and
blood pressure was the most important risk factor for disease cannot definitively be concluded from a case-
stroke. A study of a population-based cohort in control design. However, our objective was to quantify
Oxfordshire, UK, evaluated the relationship between the effect of known risk factors on burden of disease,
premorbid blood pressure and acute post-stroke blood rather than to establish new causal relationships, which
pressure, and we used this study’s findings to estimate has already been done for most of the risk factors we
expected preadmission blood pressure for patients.14 We assessed in prospective cohort studies and randomised
chose adjusted blood pressure at the time of hospital controlled trials.
admission to estimate blood pressure because it represents Our study has several strengths, particularly the large
a single, consistent timepoint in all patients, is not affected representative sample of individuals with stroke from all
by use of in-hospital blood pressure drugs (which might major regions of the world, which has not been used in any
have regional variability in use), and is not influenced by other study. A case-control design provides a practical
medical complications after stroke. We used a single approach to measuring the importance of risk factors for
measurement in cases, rather than mean of three stroke worldwide. Although prospective cohort studies,
measurements, because blood pressure in controls was such as in the PURE study, provide a more methodologically
measured on one occasion. However, we did several rigorous design than case-control studies, they need a
sensitivity analyses, using different approaches to define considerably larger number of participants, greater
hypertension by blood pressure measurement in cases resources, logistics, and duration of follow-up. Extended
(appendix p 4). Our primary estimate of PAR association follow-up of large prospective cohort studies (eg, PURE,43
with hypertension is generally consistent with estimates Kadoorie,47 and UK Biobank48) will provide additional
derived from previous studies, and lower than that insights and clarification with prospective assessment of
reported by the GBD analyses.7 For atrial fibrillation (and the importance of these risk factors for stroke risk, and
other cardiac causes), more measurements were taken in other cardiovascular diseases. Additionally, further research
cases than controls, although use of cardiac diagnostics is needed for niche populations not included in
was low in the entire cohort, with marked regional INTERSTROKE (eg, specific indigenous groups from
variations, meaning that the true prevalence of atrial around the world).
fibrillation is expected to be higher than reported, In conclusion, ten potentially modifiable risk factors are
particularly in low-income and middle-income countries. collectively associated with about 90% of the PAR of stroke
We chose apolipoproteins and HbA1c, because these in each major region of the world, in ethnic groups, in men
measurements are less affected by non-fasting status than and women, and in different age groups. However, we
lipoproteins and glucose, respectively.45,46 found important regional variations in the relative
Choice of controls might also affect the prevalence of risk importance of most individual risk factors for stroke, which
factors in the control group. We recruited both community- could contribute to worldwide variations in frequency and
based and hospital-based controls, which allowed us to case-mix of stroke and support the development of both
assess whether the results depended on how controls were global and region-specific programmes to prevent stroke.
selected, and observe some modest difference in magnitude Contributors
of association for some risk factors (appendix p 12), but this MJO’D and SY designed the study, planned analyses, and wrote the first
did not materially alter our overall findings. Any such bias draft of the report. PR-M and XZ did statistical analyses. All authors
contributed to the collection of data, discussions and interpretation of the
might also influence apparent regional variations in relative data, and to the writing of the report. All authors had full access to data
magnitude of association because some regions had larger and reviewed and approved the drafts of the report.
proportions of hospital-based controls than others. For Declaration of interests
example, inclusion of hospital controls could increase the GJH reports personal fees from Bayer and Medscape, outside of the
prevalence of diseases that have independent associations submitted work. H-CD has received honoraria for participation in
clinical trials, contribution to advisory boards, or oral presentations 12 Bonita R, Beaglehole R. Recovery of motor function after stroke.
from Abbott, Allergan, AstraZeneca, Bayer Vital, Bristol-Myers Squibb, Stroke 1988; 19: 1497–500.
Boehringer Ingelheim, CoAxia, Corimmun, Covidien, Daiichi-Sankyo, 13 Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable
D-Pharm, Fresenius, GlaxoSmithKline, Janssen-Cilag, risk factors associated with myocardial infarction in 52 countries (the
Johnson & Johnson, Knoll, Lilly, MSD, Medtronic, MindFrame, INTERHEART study): case-control study. Lancet 2004; 364: 937–52.
Neurobiological Technologies, Novartis, Novo-Nordisk, Paion, 14 Fischer U, Cooney MT, Bull LM, et al. Acute post-stroke blood
Parke-Davis, Pfizer, Sanofi-Aventis, Schering-Plough, Servier, Solvay, pressure relative to premorbid levels in intracerebral haemorrhage
Syngis, Talecris, Thrombogenics, WebMD Global, Wyeth, and versus major ischaemic stroke: a population-based study.
Yamanouchi; financial support for research projects provided by Lancet Neurol 2014; 13: 374–84.
AstraZeneca, GlaxoSmithKline, Boehringer Ingelheim, Lundbeck, 15 Dehghan M, Mente A, Teo KK, et al. Relationship between healthy
Novartis, Janssen-Cilag, Sanofi-Aventis, Syngis, and Talecris; served as diet and risk of cardiovascular disease among patients on drug
therapies for secondary prevention: a prospective cohort study of
editor of Aktuelle Neurologie, Arzneimitteltherapie, Kopfschmerznews,
31 546 high-risk individuals from 40 countries. Circulation 2012;
Stroke News, and the Treatment Guidelines of the German Neurological 126: 2705–12.
Society within the past year; and served as co-editor of Cephalalgia, and
16 Chiuve SE, Fung TT, Rimm EB, et al. Alternative dietary indices
on the editorial board of Lancet Neurology, Stroke, European Neurology, both strongly predict risk of chronic disease. J Nutr 2012;
and Cerebrovascular Disorders in the past year. MJO’D, SLC, SR, DX, LL, 142: 1009–18.
HZ, PR-M, XZ, PP, SA, PL-J, AD, PL, MJM, AR, MD, ALD, AE, AA, CM, 17 Smyth A, Teo KK, Rangarajan S, et al. Alcohol consumption and
DR, AC, NP, CW, RI, RD, KY, AY, AO, XW, EP, FL, OSO, AO, HKI, GM, cardiovascular disease, cancer, injury, admission to hospital, and
ZR, SO, FAH, DM, YN, JF, GP, and SY declare no competing interests. mortality: a prospective cohort study. Lancet 2015; 386: 1945–54.
Acknowledgments 18 Benichou J, Gail MH. Variance calculations and confidence
The INTERSTROKE study was funded by the Canadian Institutes of intervals for estimates of the attributable risk based on logistic
Health Research, Heart and Stroke Foundation of Canada, Canadian models. Biometrics 1990; 46: 991–1003.
Stroke Network, Swedish Research Council, Swedish Heart and Lung 19 Eide GE, Heuch I. Average attributable fractions: a coherent theory
for apportioning excess risk to individual risk factors and
Foundation, The Health & Medical Care Committee of the Regional
subpopulations. Biom J 2006; 48: 820–37.
Executive Board, Region Västra Götaland (Sweden), and through
20 Ferguson J, Alvarez-Iglesias A, Newell J, Hinde J, O’Donnell M.
unrestricted grants from several pharmaceutical companies with major
Estimating average attributable fractions with confidence intervals
contributions from AstraZeneca, Boehringer Ingelheim (Canada), Pfizer
for cohort and case–control studies. Stat Methods Med Res 2016;
(Canada), MSD, Swedish Heart and Lung Foundation, Chest, Heart and published online June 24. DOI:10.1177/0962280216655374.
Stroke Scotland, and The Stroke Association, with support from The UK
21 Peters SA, Singhateh Y, Mackay D, Huxley RR, Woodward M.
Stroke Research Network. The Department of Neurology at the Total cholesterol as a risk factor for coronary heart disease and
University Duisburg-Essen received research grants awarded to H-CD stroke in women compared with men: a systematic review and
from the German Research Council (DFG), German Ministry of meta-analysis. Atherosclerosis 2016; 248: 123–31.
Education and Research (BMBF), European Union, National Institutes 22 Lock K, Pomerleau J, Causer L, Altmann DR, McKee M. The global
of Health, Bertelsmann Foundation, and Heinz-Nixdorf Foundation. burden of disease attributable to low consumption of fruit and
vegetables: implications for the global strategy on diet.
References
Bull World Health Organ 2005; 83: 100–08.
1 Feigin VL, Mensah GA, Norrving B, Murray CJ, Roth GA, for the GBD
2013 Stroke Panel Experts Group. Atlas of the Global Burden of Stroke 23 Kontogianni MD, Panagiotakos DB. Dietary patterns and stroke:
(1990–2013): the GBD 2013 Study. Neuroepidemiology 2015; 45: 230–36. a systematic review and re-meta-analysis. Maturitas 2014; 79: 41–47.
2 Norrving B, Davis SM, Feigin VL, et al. Stroke prevention 24 Micha R, Khatibzadeh S, Shi P, Andrews KG, Engell RE,
worldwide-what could make it work? Neuroepidemiology 2015; Mozaffarian D. Global, regional and national consumption of major
45: 215–20. food groups in 1990 and 2010: a systematic analysis including
266 country-specific nutrition surveys worldwide. BMJ Open 2015;
3 O’Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and
5: e008705.
intracerebral haemorrhagic stroke in 22 countries (the
INTERSTROKE study): a case-control study. Lancet 2010; 25 Singh PN, Arthur KN, Orlich MJ, et al. Global epidemiology of
376: 112–23. obesity, vegetarian dietary patterns, and noncommunicable disease
in Asian Indians. Am J Clin Nutr 2014; 100 (suppl 1): 359S–64S.
4 O’Donnell M, Yusuf S. Tackling the global burden of stroke: the
need for large-scale international studies. Lancet Neurol 2009; 26 Leong DP, Smyth A, Teo KK, et al. Patterns of alcohol consumption
8: 306–07. and myocardial infarction risk: observations from 52 countries in
the INTERHEART case-control study. Circulation 2014; 130: 390–98.
5 Feigin VL, Krishnamurthi R, Bhattacharjee R, et al. New strategy to
reduce the global burden of stroke. Stroke 2015; 46: 1740–47. 27 Chow CK, Teo KK, Rangarajan S, et al. Prevalence, awareness,
treatment, and control of hypertension in rural and urban
6 Feigin VL, Krishnamurthi RV, Parmar P, et al. Update on the global
communities in high-, middle-, and low-income countries. JAMA
burden of ischemic and hemorrhagic stroke in 1990−2013: the GBD
2013; 310: 959–68.
2013 Study. Neuroepidemiology 2015; 45: 161−76.
28 Hyun KK, Huxley RR, Arima H, et al. A comparative analysis of
7 GBD 2013 Risk Factors Collaborators. Global, regional, and national
risk factors and stroke risk for Asian and non-Asian men: the Asia
comparative risk assessment of 79 behavioural, environmental and
Pacific cohort studies collaboration. Int J Stroke 2013; 8: 606–11.
occupational, and metabolic risks or clusters of risks in
188 countries, 1990−2013: a systematic analysis for the Global 29 Eastwood SV, Tillin T, Chaturvedi N, Hughes AD. Ethnic differences
Burden of Disease Study 2013. Lancet 2015; 386: 2287−323. in associations between blood pressure and stroke in South Asian
and European Men. Hypertension 2015; 66: 481–88.
8 Feigin VL, Roth GA, Naqhavi M, et al Global burden of stroke and
risk factors in 188 countries, during 1990–2013: a systematic 30 McGrath ER, Kapral MK, Fang J, et al. Association of atrial
analysis for the Global Burden of Disease Study 2013. Lancet Neurol fibrillation with mortality and disability after ischemic stroke.
2016; published online June 9. http://dx.doi.org/10.1016/S1474- Neurology 2013; 81: 825–32.
4422(16)30073-4. 31 Vibha D, Prasad K. Cerebrovascular disease in South Asia—part II:
9 Yusuf S, McKee M. Documenting the global burden of risk factors and prevention. JRSM Cardiovasc Dis 2012; 1: 21.
cardiovascular disease: a major achievement but still a work in 32 Wang C, Yang Z, Wang C, et al. Significant underuse of warfarin in
progress. Circulation 2014; 129: 1459–62. patients with nonvalvular atrial fibrillation: results from the China
10 O’Donnell M, Xavier D, Diener C, et al. Rationale and design of national stroke registry. J Stroke Cerebrovasc Dis 2014; 23: 1157–63.
INTERSTROKE: a global case-control study of risk factors for 33 Saposnik G, Del Brutto OH, for the Iberoamerican Society of
stroke. Neuroepidemiology 2010; 35: 36–44. Cerebrovascular Diseases. Stroke in South America: a systematic
11 Hatano S. Experience from a multicentre stroke register: review of incidence, prevalence, and stroke subtypes. Stroke 2003;
a preliminary report. Bull World Health Organ 1976; 54: 541–53. 34: 2103–07.
34 Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide 42 Zhao D, Liu J, Wang W, et al. Epidemiological transition of stroke in
epidemiology of atrial fibrillation: a Global Burden of Disease 2010 China: twenty-one-year observational study from the
Study. Circulation 2014; 129: 837–47. Sino-MONICA-Beijing Project. Stroke 2008; 39: 1668–74.
35 Rodriguez CJ, Soliman EZ, Alonso A, et al. Atrial fibrillation 43 Yusuf S, Rangarajan S, Teo K, et al. Cardiovascular risk and events
incidence and risk factors in relation to race-ethnicity and the in 17 low-, middle-, and high-income countries. N Engl J Med 2014;
population attributable fraction of atrial fibrillation risk factors: 371: 818–27.
the Multi-Ethnic Study of Atherosclerosis. Ann Epidemiol 2015; 44 Rowe AK, Powell KE, Flanders WD. Why populations attributable
25: 71–76. fractions can sum to more than one. Am J Prev Med 2004;
36 Huxley RR, Hirakawa Y, Hussain MA, et al. Age- and sex-specific 365: 1434–37.
burden of cardiovascular disease attributable to 5 major and 45 McQueen MJ, Hawken S, Wang X, et al. Lipids, lipoproteins, and
modifiable risk factors in 10 Asian countries of the Western Pacific apolipoproteins as risk markers of myocardial infarction in
region. Circ J 2015; 79: 1662–74. 52 countries (the INTERHEART study): a case-control study. Lancet
37 Willey JZ, Moon YP, Kahn E, et al. Population attributable risks of 2008; 372: 224–33.
hypertension and diabetes for cardiovascular disease and stroke in 46 Gerstein HC, Islam S, Anand S, et al. Dysglycaemia and the risk of
the northern Manhattan study. J Am Heart Assoc 2014; 3: e001106. acute myocardial infarction in multiple ethnic groups: an analysis
38 Hajat C, Tilling K, Stewart JA, Lemic-Stojcevic N, Wolfe CD. of 15,780 patients from the INTERHEART study. Diabetologia 2010;
Ethnic differences in risk factors for ischemic stroke: a European 53: 2509–17.
case-control study. Stroke 2004; 35: 1562–67. 47 Chen Z, Chen J, Collins R, et al. China Kadoorie Biobank of
39 Bos MJ, Koudstaal PJ, Hofman A, Ikram MA. Modifiable etiological 0·5 million people: survey methods, baseline characteristics and
factors and the burden of stroke from the Rotterdam study: long-term follow-up. Int J Epidemiol 2011; 40: 1652–66.
a population-based cohort study. PLoS Med 2014; 11: e1001634. 48 Sudlow C, Gallacher J, Allen N, et al. UK biobank: an open access
40 Poulter NR, Prabhakaran D, Caulfield M. Hypertension. Lancet resource for identifying the causes of a wide range of complex
2015; 386: 801–12. diseases of middle and old age. PLoS Med 2015; 12: e1001779.
41 Andersen KK, Olsen TS, Dehlendorff C, Kammersgaard LP.
Hemorrhagic and ischemic strokes compared: stroke severity,
mortality, and risk factors. Stroke 2009; 40: 2068–72.